Image For Activity Cover
Antithrombotic Therapy After LAAO: Changes in Care - 2023 Quality Summit Presentation (Non-CE)

Antithrombotic Therapy After LAAO: Changes in Care


Abhijeet Dhoble, MD, FACC - Director, Structural Heart Interventions, University of Texas Health Science Center, Houston


Julie Mobayed, MPH, BSN, RN, CPHQ, AACC - Director, LAAO Registry Program Manager, National Quality Campaigns, American College of Cardiology

This session will discuss the changes in Antithrombotic therapy after patients receive an LAAO device including: DAPT Therapy, Changing Strategies and Bleeding Events. 

Learning Objectives:

  • Recognize at least one change in antithrombotic medications, dosing, and duration for LAAO patients.
  • Identify strategies for prescription writing, patient communications, follow-up monitoring, and provider communications.
  • Recognize the potential for bleeding events with antithrombotic therapy changes.
Availability: On-Demand
Expires on Feb 07, 2027
Credit Offered:
No Credit Offered
Powered By